Effect of multiplicity, laterality, and age at onset of breast cancer on familial risk of breast cancer: a nationwide prospective cohort study

被引:0
|
作者
Elham Kharazmi
Tianhui Chen
Steven Narod
Kristina Sundquist
Kari Hemminki
机构
[1] German Cancer Research Center,Division of Molecular Genetic Epidemiology
[2] Canada Research Chair in Breast Cancer,Departments of Public Health Sciences and Nutritional Sciences
[3] Lund University,Center for Primary Health Care Research
[4] Stanford University School of Medicine,Stanford Prevention Research Center
来源
关键词
Familial breast cancer; Contralateral breast cancer; Multiple ipsilateral breast cancers; Age at onset;
D O I
暂无
中图分类号
学科分类号
摘要
The objective of this nationwide prospective cohort study is to find out the risk of breast cancer (BC) in relatives of patients with multiple BCs by laterality and age at diagnosis of first BC. Having family history of single (HR 1.8; 95 % CI 1.8–1.9) or multiple (HR 2.7; 95 % CI 2.6–2.9) BC was associated with higher risk of BC. Those with an FDR with contralateral BC at any age had the highest risk of familial cancer except at age <40 in which those whose young FDR was affected by multiple ipsilateral BC had the highest risk (HR 9.7; 95 % CI 6.0–15.6). The familial risk of BC in these families decreased as the subject’s and FDRs’ age at diagnosis of first BC increased. The HR was still significantly increased (2.2) for old individuals (>60) having a FDR with contralateral BC at an advanced age (≥80). Despite the common belief that later onset breast cancer is more associated with sporadic breast cancer, our data suggest that breast cancer at any age in the family is associated with some increase in the familial risk, though that risk decreases as the age of onset increases. Contralateral and multiple ipsilateral breast cancers might be associated with distinct shared familial risk factors. Our results have implication for genetic counseling and urge gene identification studies.
引用
收藏
页码:185 / 192
页数:7
相关论文
共 50 条
  • [1] Effect of multiplicity, laterality, and age at onset of breast cancer on familial risk of breast cancer: a nationwide prospective cohort study
    Kharazmi, Elham
    Chen, Tianhui
    Narod, Steven
    Sundquist, Kristina
    Hemminki, Kari
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 144 (01) : 185 - 192
  • [2] Familial risk of early and late onset cancer: nationwide prospective cohort study
    Kharazmi, E.
    Fallah, M.
    Sundquist, K.
    Hemminki, K.
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 345
  • [3] Survival in familial breast cancer: Novel findings based on a nationwide prospective cohort study
    Kharazmi, Elham
    Foersti, Asta
    Sundquist, Kristina
    Hemminki, Kari
    CANCER RESEARCH, 2014, 74 (19)
  • [4] AGE AT ONSET AS AN INDICATOR OF FAMILIAL RISK OF BREAST-CANCER
    CLAUS, EB
    RISCH, NJ
    THOMPSON, D
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1990, 131 (06) : 961 - 972
  • [5] AGE AT ONSET AS AN INDICATOR OF FAMILIAL RISK OF BREAST-CANCER
    BLETTNER, M
    EBY, NL
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1992, 135 (01) : 105 - 105
  • [6] Statin Prescriptions and Breast Cancer Recurrence Risk: A Danish Nationwide Prospective Cohort Study
    Ahern, Thomas P.
    Pedersen, Lars
    Tarp, Maja
    Cronin-Fenton, Deirdre P.
    Garne, Jens Peter
    Silliman, Rebecca A.
    Sorensen, Henrik Toft
    Lash, Timothy L.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (19): : 1461 - 1468
  • [7] AGE AT ONSET AS AN INDICATOR OF FAMILIAL RISK OF BREAST-CANCER - REPLY
    CLAUS, EB
    RISCH, NJ
    THOMPSON, WD
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1992, 135 (01) : 106 - 106
  • [8] Risk of breast cancer in risperidone users: A nationwide cohort study
    Reutfors, Johan
    Wingard, Louise
    Brandt, Lena
    Wang, Yiting
    Qiu, Hong
    Kieler, Helle
    Bahmanyar, Shahram
    SCHIZOPHRENIA RESEARCH, 2017, 182 : 98 - 103
  • [9] Hypothyroidism and hyperthyroidism and breast cancer risk: a nationwide cohort study
    Sogaard, Mette
    Farkas, Dora Kormendine
    Ehrenstein, Vera
    Jorgensen, Jens Otto Lunde
    Dekkers, Olaf M.
    Sorensen, Henrik Toft
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2016, 174 (04) : 409 - 414
  • [10] Risk of Breast Cancer in Risperidone Users: A Nationwide Cohort Study
    Reutfors, Johan
    Wingard, Louise
    Brandt, Lena
    Wang, Yiting
    Qiu, Hong
    Kieler, Helle
    Bahmanyar, Shahram
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 466 - 466